WASHINGTON — The Trump administration is being flooded with opposition to its plan for allowing states to import cheaper drugs from Canada.
In December, the administration released a draft plan that would allow states to partner with drug wholesalers to import drugs from Canada. A number of states, including Florida, Colorado, and Maine, are already champing at the bit to start importing, but the Trump administration will have to overcome monumental opposition from nearly every corner of the drug supply chain if it wants to finalize the pathway that will make that possible.
Pharmacists from Vermont to Alabama, biotechnology companies from coast to coast, sheriffs, and even upset Canadians all weighed in in recent weeks to oppose the Trump administration’s plan. More than 900 individuals also took part in a letter writing campaign organized by the Partnership for Safe Medicines, an anti-importation nonprofit with deep ties to the drug industry.